Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenesis, evaluation, and therapy for massive hemoptysis.

A B Thompson1, H Teschler, S I Rennard

  • 1Department of Internal Medicine, University of Nebraska Medical Center, Omaha.

Clinics in Chest Medicine
|March 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

REACH-OUT: Race, Ethnicity, and Air Pollution in COVID-19 Hospitalization OUTcomes.

Research report (Health Effects Institute)·2025
Same author

[Update of the AWMF S2k Guideline "Diagnostics and Assessment of Occupational Asbestos-Related Diseases" - What's New?]

Pneumologie (Stuttgart, Germany)·2021
Same author

[Changes to the Law on Occupational Diseases and Consequences for Medical Assessment].

Pneumologie (Stuttgart, Germany)·2020
Same author

Association of time under immunosuppression and different immunosuppressive medication on periodontal parameters and selected bacteria of patients after solid organ transplantation.

Medicina oral, patologia oral y cirugia bucal·2018
Same author

[Guideline (S2k, AWMF) of the Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin and the Deutsche Gesellschaft für Arbeitsmedizin und Umweltmedizin "Diagnostics and Expert Opinion in the Occupational Disease No. 4101 Silicosis (Including Coal Worker's Pneumoconiosis)"].

Pneumologie (Stuttgart, Germany)·2016
Same author

[Sleep medicine: new data].

Deutsche medizinische Wochenschrift (1946)·2014
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Massive hemoptysis, a rare but deadly condition, requires immediate airway control to prevent fatal blood aspiration. While surgery is definitive, conservative measures can manage acute bleeding and offer alternatives for non-surgical patients.

Area of Science:

  • Pulmonology
  • Critical Care Medicine

Background:

  • Massive hemoptysis presents a significant threat to life, primarily due to the risk of airway compromise from blood aspiration.
  • Prompt management is crucial, integrating airway control with initial patient assessment.

Observation:

  • The primary cause of mortality in massive hemoptysis is aspiration of blood, necessitating simultaneous airway management and evaluation.
  • Understanding the pathophysiology and blood loss rate guides therapeutic interventions.

Findings:

  • Surgical intervention is the definitive treatment for massive hemoptysis.
  • Non-surgical approaches can effectively control acute bleeding and serve as alternatives for patients unsuitable for surgery.

Implications:

Related Experiment Videos

  • Effective management strategies for massive hemoptysis balance immediate life support with definitive treatment planning.
  • Conservative measures expand treatment options, improving outcomes for a broader range of patients with life-threatening hemoptysis.